Genova CDSA

The Comprehensive Digestive Stool Analysis (CDSA)™ offers a comprehensive look at the overall health of the gastrointestinal (GI) tract. The CDSA™ is Genova’s historic evaluation of gastrointestinal function assessing a select set of stool biomarkers.

This stool analysis evaluates:

• Digestion/Absorption Markers
• Gut Metabolic Markers
• Gut Microbiology Markers

This diagnostic stool analysis provides immediate, actionable clinical information for the estimated 50% of patients seen by primary care practitioners who have gastrointestinal complaints. For greater insight into the clinical utility of the CDSA™, please read the Clinical Overview below.

• Digestion/Absorption:
  • Chymotrypsin
  • Putrefactive Short–Chain Fatty Acids
  • Meat and Vegetable Fibers
  • Fecal Fats
• Gut Metabolic Markers
  • Beneficial Short–Chain Fatty Acids (SCFA) with n–Butyrate
  • n–Butyrate
  • Beta-Glucuronidase
  • pH
  • SCFA distribution
  • Fecal Lactoferrin
  • Macroscopic (color, mucus)
  • Occult Blood
• Gut Microbiology Markers
  • Beneficial Bacteria
  • Additional Bacteria
  • Mycology

When should CDSA™ be considered?

CDSA can reveal important clinical information about many common symptoms such as gas, bloating, abdominal pain, diarrhea, and constipation. Fecal Lactoferrin and Occult Blood provide insight into potential gut inflammation.